Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gritstone Bio Inc (NQ: GRTS ) 0.5712 +0.0012 (+0.21%) Streaming Delayed Price Updated: 3:37 PM EDT, Jul 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Gritstone Bio Inc < Previous 1 2 3 4 Next > Gritstone Says Omicron Mutations Minimally Impact T-Cell Epitope Sequences In Its COVID-19 Vaccines November 29, 2021 Gritstone bio Inc (NASDAQ: GRTS) announced that the SARS-CoV-2 T cell epitopes (TCEs) administered within its self-amplifying mRNA (SAM) COVID-19 vaccines are minimally... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO November 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business August 17, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session November 04, 2021 Gainers Evaxion Biotech (NASDAQ:EVAX) shares increased by 244.61% to $22.4 during Thursday's pre-market session. The company's market cap stands at $430.0 million... Via Benzinga Does This Biotech Have the Secret to Conquering Covid Variants? September 29, 2021 The company uses mRNA technology -- with a new twist. Via The Motley Fool Exposures COVID-19 48 Biggest Movers From Friday September 20, 2021 Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by... Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session September 17, 2021 Gainers Corvus Pharmaceuticals (NASDAQ:CRVS Via Benzinga Gritstone Unveils "Off-The-Shelf" Neoantigen Immunotherapy Data In Lung Cancer September 17, 2021 Gritstone bio Inc (NASDAQ: GRTS) has announced results with its SLATE v1 product ("off-the-shelf" shared neoantigen immunotherapy). The therapy is in... Via Benzinga Gritstone Presents Data From Individualized Neoantigen Immunotherapy In Colorectal Cancer September 17, 2021 Gritstone bio Inc (NASDAQ: GRTS) has announced updated results from the Phase 1/2 study of GRANITE individualized neoantigen immunotherapy in advanced solid tumors... Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session September 17, 2021 Gainers Corvus Pharmaceuticals (NASDAQ:CRVS) stock moved upwards by 53.98% to $3.48 during Friday's pre-market session. The company's market cap stands at $147.6... Via Benzinga 5 Stocks To Watch For September 17, 2021 September 17, 2021 Some of the stocks that may grab investor focus today are: Wall Street expects Manchester United plc (NYSE: MANU) to report a quarterly loss at $0.15 per share on revenue of $... Via Benzinga The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold September 17, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (... Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session September 16, 2021 Gainers Stealth BioTherapeutics (NASDAQ: Via Benzinga 3 Explosive Biotech Stocks That Could 10X in 10 Years September 16, 2021 They're leaders in therapeutic areas with massive growth potential. Via The Motley Fool The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs September 12, 2021 Biotech stocks retreated in the holiday-shortened week ending Sept. 10, reversing course from the previous week. Humanigen, Inc. (NASDAQ: HGEN) was among the biggest... Via Benzinga Exposures COVID-19 Product Safety Gritsone Bio Secures CEPI Funding For Its Differentiated COVID-19 Vaccine Candidate August 17, 2021 Gritstone bio Inc (NASDAQ: GRTS) has entered into a funding agreement of up to $20.6 million with the Coalition for Epidemic Preparedness Innovations (CEPI). The... Via Benzinga Exposures COVID-19 Cramer Advises Viewers On Palantir, SoFi And More August 04, 2021 On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't understand why is MKS Instruments, Inc. (NASDAQ: MKSI) trading so cheap. He would be a buyer.... Via Benzinga 58 Biggest Movers From Yesterday August 20, 2021 Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares climbed 63.7% to close at $1.22 on Thursday after dropping 12% on Wednesday. Sonnet BioTherapeutics recently... Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session July 30, 2021 Gainers NanoVibronix (NASDAQ:NAOV) share... Via Benzinga 3 Top Biotech Picks for June June 19, 2021 Coronavirus players may deliver strong returns well into the future. Via The Motley Fool Exposures COVID-19 12 Health Care Stocks Moving In Friday's After-Market Session June 04, 2021 Gainers Cyclacel Pharmaceuticals (NASDAQ:CYCC... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.